Related Experiment Video
Updated: Dec 9, 2025

05:34
Author Spotlight: Advancing Pathogen Diagnostics with Standardized LAMP
Published on: September 8, 2023
1.1K
SARS-CoV-2 detection using isothermal amplification and a rapid, inexpensive protocol for sample inactivation and
Brian A Rabe1, Constance Cepko2,3,4
1Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA 02115.
Summary
A new diagnostic assay for SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) offers rapid, sensitive detection. This reverse-transcription loop-mediated isothermal amplification (RT-LAMP) test can identify as few as 1 viral RNA copy per microliter.
Area of Science:
- Molecular Biology
- Virology
- Diagnostics
Background:
- The SARS-CoV-2 pandemic necessitates expanded diagnostic capabilities for safe economic reopening.
- Current testing methods face limitations in speed, sensitivity, and accessibility.
- Rapid and reliable diagnostics are crucial for controlling viral spread.
Purpose of the Study:
- To develop a sensitive and rapid diagnostic assay for SARS-CoV-2 detection.
- To create an efficient sample preparation protocol compatible with the assay.
- To enhance the accessibility and scalability of SARS-CoV-2 testing.
Main Methods:
- Development of a sensitive reverse-transcription loop-mediated isothermal amplification (RT-LAMP) assay.
- Optimization of a rapid viral inactivation and nuclease degradation protocol.
- Integration of a compatible RNA purification method to maximize sensitivity.
- Utilized a colorimetric readout for results within 30 minutes.
Main Results:
- The RT-LAMP assay achieved a sensitivity of 50 viral RNA copies/µL with rapid inactivation alone.
- The combined inactivation and purification protocol increased sensitivity to 1 viral RNA copy/µL.
- The assay demonstrated compatibility with existing reagents and provided results in under 30 minutes.
- The developed pipeline is inexpensive and uses readily available materials.
Conclusions:
- A simple, sensitive, and rapid RT-LAMP assay pipeline for SARS-CoV-2 detection has been established.
- This method significantly enhances diagnostic sensitivity and sample stability.
- The assay's affordability and compatibility expand testing capabilities and settings, aiding pandemic control efforts.

